The clinicopathological significance of FHIT hypermethylation in non-small cell lung cancer, a meta-analysis and literature review
Authors:
Open Access
- 22 January 2016
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , srep19303-19303
Abstract
Emerging evidence indicates that FHIT is a candidate tumor suppressor in non-small cell lung cancer (NSCLC). However, the correlation between FHIT hypermethylation and clinicopathological characteristics of NSCLC remains unclear. Thus, we conducted a meta-analysis to quantitatively evaluate the effects of FHIT hypermethylation on the incidence of NSCLC and clinicopathological characteristics. Final analysis of 1717 NSCLC patients from 16 eligible studies was performed. FHIT hypermethylation was found to be significantly higher in NSCLC than in normal lung tissue, the pooled OR from 8 studies including 735 NSCLC and 708 normal lung tissue, OR = 5.45, 95% CI = 2.15–13.79, p = 0.0003. FHIT hypermethylation was also correlated with sex status, smoking status, as well as pathological types. We did not find that FHIT hypermethylation was correlated with the differentiated types or clinical stages in NSCLC patients. However, patients with FHIT hypermethylation had a lower survival rate than those without, HR = 1.73, 95% CI = 1.10–2.71, p = 0.02. The results of this meta-analysis suggest that FHIT hypermethylation is associated with an increased risk and worsen survival in NSCLC patients. FHIT hypermethylation, which induces the inactivation of FHIT gene, plays an important role in the carcinogenesis and clinical outcome and may serve as a potential drug target of NSCLC.Keywords
This publication has 58 references indexed in Scilit:
- DNA Methylation and Cancer DiagnosisInternational Journal of Molecular Sciences, 2013
- Reduced FHIT Expression Is Associated with Mismatch Repair Deficient and High CpG Island Methylator Phenotype Colorectal CancerJournal of Histochemistry & Cytochemistry, 2013
- Intramitochondrial calcium regulation by the FHIT gene product sensitizes to apoptosisProceedings of the National Academy of Sciences, 2009
- Fhit Tumor Suppressor: Guardian of The Preneoplastic GenomeFuture Oncology, 2008
- Fhit Interaction with Ferredoxin Reductase Triggers Generation of Reactive Oxygen Species and Apoptosis of Cancer CellsJournal of Biological Chemistry, 2008
- Aberrant methylation of Fragile Histidine Triad gene is associated with poor prognosis in early stage esophageal squamous cell carcinomaEuropean Journal of Cancer, 2006
- 5′CpG island hypermethylation and aberrant transcript splicing both contribute to the inactivation of the FHIT gene in resected non-small cell lung cancerEuropean Journal of Cancer, 2004
- CpG methylation in the Fhit regulatory region: relation to Fhit expression in murine tumorsOncogene, 2004
- Measuring inconsistency in meta-analysesBMJ, 2003
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986